Zomedica Corp.
Zomedica Corp.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 7 | 9 | 9 | 7 | 8 | 9 | 7 | 10 | 8 | 11 | 13 | 22 | |||||
Debt Securities Available For Sale Excluding Accru… | 37 | 38 | 44 | 46 | 50 | 55 | 64 | 67 | 72 | 72 | 78 | 84 | |||||
Accounts Receivable Net Current | 6 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | |||||
Inventory Net | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 6 | 5 | 5 | 4 | |||||
Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | |||||
Other Receivables Net Current | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets Current | 58 | 60 | 64 | 65 | 69 | 73 | 82 | 87 | 89 | 92 | 100 | 115 | |||||
Prepaid Expense And Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 20 | 20 | 21 | 21 | 22 | 22 | 25 | 26 | 25 | 24 | 23 | 8 | |||||
Operating Lease Right Of Use Asset | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Goodwill | - | - | 0 | 0 | 0 | - | 46 | 46 | 46 | 62 | 62 | 74 | |||||
Intangible Assets Net Excluding Goodwill | 37 | 38 | 39 | 40 | 41 | 43 | 53 | 52 | 53 | 55 | 55 | 57 | |||||
Debt Securities Available For Sale Excluding Accru… | - | - | - | 1 | 1 | 1 | - | 1 | 3 | 8 | 10 | 12 | |||||
Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 118 | 122 | 127 | 131 | 136 | 143 | 207 | 214 | 220 | 244 | 253 | 275 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | 7 | 8 | 6 | |||||
Accrued Income Taxes | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Accounts Payable Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - | 2 | - | |||||
Accrued Income Taxes Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Accrued Liabilities Current | 6 | 5 | 6 | 6 | 5 | 4 | 6 | 5 | 4 | - | 6 | - | |||||
Liabilities Current | 9 | 9 | 9 | 8 | 8 | 7 | 9 | 8 | 8 | 8 | 9 | 7 | |||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | |||||
Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Contract With Customer Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 11 | 11 | 12 | 11 | 11 | 11 | 12 | 11 | 11 | 12 | 13 | 14 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | 381 | |||||
Additional Paid In Capital Common Stock | 34 | 34 | 34 | 34 | 33 | 33 | 33 | 32 | 32 | 31 | 30 | 29 | |||||
Retained Earnings Accumulated Deficit | -308 | -304 | -300 | -295 | -289 | -282 | -218 | -211 | -204 | -180 | -171 | -149 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | |||||
Stockholders Equity | 107 | 111 | 115 | 120 | 125 | 132 | 196 | 203 | 209 | 232 | 240 | 261 | |||||
Liabilities And Stockholders Equity | 118 | 122 | 127 | 131 | 136 | 143 | 207 | 214 | 220 | 244 | 253 | 275 | |||||
Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Issued | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | |||||
Shares Outstanding | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | 980 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 11.96% | 4.35% | -5.43% | - | - | - | - | - | - | - | - | - |
| 2025 | -23.73% | -33.90% | -33.90% | 18.92% | 118.92% | 91.89% | 51.95% | 40.26% | 71.43% | -11.72% | -10.16% | -22.66% |
| 2024 | 5.03% | -8.18% | -5.03% | -18.06% | -10.97% | -22.58% | 4.92% | -0.82% | 1.64% | 47.22% | 47.22% | 33.33% |
| 2023 | - | - | - | -8.70% | -19.32% | -25.12% | -5.56% | -0.56% | -26.67% | -5.00% | 25.71% | 4.29% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 6.43 | 7.01 | 6.78 | 7.67 | 8.44 | 9.89 | 8.76 | 10.82 | 11.39 | 11.50 | 11.06 | 17.12 | |||||
| Quick Ratio | 5.57 | 6.11 | 6.00 | 6.73 | 7.50 | 8.88 | 7.98 | 9.83 | 10.42 | 10.66 | 10.26 | 16.12 | |||||
| Working Capital | 48.89M | 51.47M | 54.59M | 56.26M | 60.48M | 65.82M | 72.44M | 79.21M | 81.39M | 84.06M | 90.85M | 108.65M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.08 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
| Interest Coverage TTM | - | - | - | - | - | - | - | -65,966.00 | -991.91 | -363.38 | -244.49 | -143.97 | |||||
| Debt Ratio | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.29 | 0.26 | 0.19 | 0.17 | 0.16 | 0.14 | 0.12 | 0.11 | 0.11 | 0.10 | 0.09 | 0.09 | |||||
| Days Sales Outstanding TTM | 39.42 | 31.88 | 30.97 | 30.38 | 23.68 | 21.34 | 24.21 | 21.22 | 14.26 | 14.60 | 12.99 | 15.71 | |||||
| Receivables Turnover TTM | 9.26 | 11.45 | 11.79 | 12.01 | 15.41 | 17.11 | 15.07 | 17.20 | 25.60 | 25.00 | 28.09 | 23.23 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | - | - | -0.08 | -0.09 | -0.09 | -0.10 | -0.05 | -0.06 | -0.06 | -0.04 | -0.04 | -0.02 | |||||
| Free Cash Flow Per Share TTM | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 | -0.03 | -0.03 | -0.02 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 65.44% | 66.29% | 67.68% | 68.10% | 69.41% | 70.40% | 69.95% | 69.64% | 68.70% | 67.78% | 68.76% | 68.55% | |||||
| Operating Profit Margin TTM | -56.28% | -71.97% | -263.36% | -296.56% | -310.99% | -382.28% | -187.11% | -246.81% | -247.24% | -177.73% | -171.82% | -105.55% | |||||
| Net Profit Margin TTM | -51.39% | -65.78% | -255.57% | -286.96% | -300.11% | -369.26% | -172.19% | -232.69% | -214.69% | -143.66% | -137.10% | -62.21% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 30.05% | 24.73% | 17.39% | 10.20% | 8.74% | 6.00% | 8.33% | 11.33% | 16.23% | 25.68% | 33.05% | 42.44% | |||||
| Net Income Growth (1Y) | -77.73% | -77.78% | 74.23% | 35.90% | 52.00% | 172.44% | 36.07% | 316.42% | 188.01% | 91.67% | 102.93% | -14.63% | |||||
| EPS Growth (1Y) | -77.73% | -77.78% | 74.23% | 35.90% | 52.00% | 172.44% | 36.07% | 316.42% | 188.01% | 91.67% | 102.93% | -14.63% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -5.17 | -5.16 | -1.22 | -0.92 | -0.46 | -0.56 | -2.50 | -2.16 | -2.56 | -3.84 | -5.68 | -10.96 | |||||
| P/B TTM | 0.91 | 1.05 | 0.87 | 0.65 | 0.31 | 0.43 | 0.60 | 0.66 | 0.69 | 0.62 | 0.82 | 0.63 | |||||
| P/S TTM | 2.66 | 3.40 | 3.12 | 2.63 | 1.38 | 2.07 | 4.31 | 5.02 | 5.49 | 5.51 | 7.78 | 6.82 | |||||
| Market Cap | 97.99M | 116.61M | 99.95M | 77.42M | 39.20M | 56.84M | 117.59M | 134.25M | 143.07M | 143.07M | 195.99M | 163.65M | |||||
| Enterprise Value | 90.80M | 107.25M | 90.94M | 69.92M | 31.07M | 48.00M | 110.57M | 124.51M | 135.13M | 132.13M | 183.04M | 141.87M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -15.28M | -16.89M | -18.50M | -15.67M | -16.84M | -25.85M | -28.84M | -30.79M | -34.42M | -32.01M | -27.31M | -22.85M | |||||
| Net Debt | -7.19M | -9.37M | -9.02M | -7.50M | -8.13M | -8.84M | -7.02M | -9.75M | -7.94M | -10.94M | -12.95M | -21.78M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Zomedica Corp. (ZOMDF) — SEC Financial Statements & Analysis
Zomedica Corp. (ZOMDF) is a pharmaceutical preparations company, incorporated in A0. Zomedica Corp. trades on OTC as: ZOMDF. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Zomedica Corp. reported a 30.05% year-over-year revenue growth, a Gross Profit Margin of 65.44% (TTM), a Debt-to-Equity ratio of 0.10x, a Price-to-Sales (P/S) ratio of 2.66x (TTM), a Price-to-Book (P/B) ratio of 0.91x (TTM), at a market cap of $97.99M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 30.05%
- Gross Profit Margin TTM
- 65.44%
- Debt To Equity
- 0.10x
- P/S TTM
- 2.66x
- P/B TTM
- 0.91x
- Market Cap
- $97.99M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Zomedica Corp. in?
Zomedica Corp. (ZOMDF) operates in the Pharmaceutical Preparations industry.
What is ZOMDF's market cap?
Zomedica Corp. (ZOMDF) has a market capitalization of $97.99M as of 2026-06-30.
What exchange does ZOMDF trade on?
Zomedica Corp. (ZOMDF) trades on the OTC.
Where is Zomedica Corp. incorporated?
Zomedica Corp. is incorporated in Alberta, Canada.